alcon ag - ALC

ALC

Close Chg Chg %
85.45 0.06 0.07%

Pre-Market

85.51

+0.06 (0.07%)

Volume: 577.49K

Last Updated:

Nov 20, 2024, 3:59 PM EDT

Company Overview: alcon ag - ALC

ALC Key Data

Open

$85.42

Day Range

85.01 - 85.67

52 Week Range

71.46 - 101.10

Market Cap

$42.14B

Shares Outstanding

493.30M

Public Float

486.74M

Beta

0.99

Rev. Per Employee

N/A

P/E Ratio

36.34

EPS

$2.35

Yield

31.66%

Dividend

$0.26

EX-DIVIDEND DATE

May 14, 2024

SHORT INTEREST

N/A

AVERAGE VOLUME

1.01M

 

ALC Performance

1 Week
 
0.35%
 
1 Month
 
-10.21%
 
3 Months
 
-11.09%
 
1 Year
 
16.20%
 
5 Years
 
50.62%
 

ALC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 30
Full Ratings ➔

About alcon ag - ALC

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland.

ALC At a Glance

Alcon AG
Royce Bedward
Geneva, Geneve (Geneva) 1214
Phone 41-817-293-04-50 Revenue 9.46B
Industry Medical Specialties Net Income 974.00M
Sector Health Technology 2023 Sales Growth 8.466%
Fiscal Year-end 12 / 2024 Employees 25,315
View SEC Filings

ALC Valuation

P/E Current 36.342
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 39.474
Price to Sales Ratio 4.095
Price to Book Ratio 1.865
Price to Cash Flow Ratio 27.898
Enterprise Value to EBITDA 17.804
Enterprise Value to Sales 4.523
Total Debt to Enterprise Value 0.12

ALC Efficiency

Revenue/Employee 373,493.976
Income Per Employee 38,475.212
Receivables Turnover 4.77
Total Asset Turnover 0.321

ALC Liquidity

Current Ratio 2.277
Quick Ratio 1.341
Cash Ratio 0.444

ALC Profitability

Gross Margin 55.568
Operating Margin 12.491
Pretax Margin 8.80
Net Margin 10.301
Return on Assets 3.312
Return on Equity 4.834
Return on Total Capital 3.78
Return on Invested Capital 3.886

ALC Capital Structure

Total Debt to Total Equity 24.947
Total Debt to Total Capital 19.966
Total Debt to Total Assets 17.374
Long-Term Debt to Equity 23.899
Long-Term Debt to Total Capital 19.128
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Alcon Ag - ALC

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
6.83B 8.29B 8.72B 9.46B
Sales Growth
-8.99% +21.34% +5.14% +8.47%
Cost of Goods Sold (COGS) incl D&A
3.76B 3.60B 3.91B 4.20B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.62B 1.22B 1.12B 1.22B
Depreciation
378.00M 404.00M 408.00M 476.00M
Amortization of Intangibles
1.25B 815.00M 715.00M 745.00M
COGS Growth
-2.84% -4.15% +8.52% +7.44%
Gross Income
3.07B 4.69B 4.81B 5.25B
Gross Income Growth
-15.53% +52.50% +2.54% +9.30%
Gross Profit Margin
+44.99% +56.54% +55.15% +55.57%
2020 2021 2022 2023 5-year trend
SG&A Expense
3.26B 3.71B 3.65B 4.04B
Research & Development
592.00M 653.00M 702.00M 828.00M
Other SG&A
2.67B 3.06B 2.95B 3.21B
SGA Growth
-5.01% +13.66% -1.59% +10.57%
Other Operating Expense
(176.00M) 69.00M 176.00M 36.00M
Unusual Expense
433.00M 329.00M 308.00M 142.00M
EBIT after Unusual Expense
(447.00M) 580.00M 672.00M 1.04B
Non Operating Income/Expense
(64.00M) (42.00M) (75.00M) (18.00M)
Non-Operating Interest Income
6.00M 3.00M 16.00M 45.00M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
124.00M 120.00M 134.00M 189.00M
Interest Expense Growth
-5.34% -3.23% +11.67% +41.04%
Gross Interest Expense
124.00M 120.00M 134.00M 189.00M
Interest Capitalized
- - - -
-
Pretax Income
(635.00M) 418.00M 463.00M 832.00M
Pretax Income Growth
-91.27% +165.83% +10.77% +79.70%
Pretax Margin
-9.29% +5.04% +5.31% +8.80%
Income Tax
(104.00M) 42.00M 128.00M (142.00M)
Income Tax - Current - Domestic
14.00M 118.00M 17.00M 74.00M
Income Tax - Current - Foreign
105.00M 116.00M 146.00M 93.00M
Income Tax - Deferred - Domestic
(96.00M) (45.00M) (53.00M) (313.00M)
Income Tax - Deferred - Foreign
(127.00M) (147.00M) 18.00M 4.00M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(531.00M) 376.00M 335.00M 974.00M
Minority Interest Expense
- - - -
-
Net Income
(531.00M) 376.00M 335.00M 974.00M
Net Income Growth
+19.05% +170.81% -10.90% +190.75%
Net Margin Growth
-7.77% +4.54% +3.84% +10.30%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(531.00M) 376.00M 335.00M 974.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
(531.00M) 376.00M 335.00M 974.00M
EPS (Basic)
-1.0859 0.7674 0.6817 1.9757
EPS (Basic) Growth
+19.19% +170.67% -11.17% +189.82%
Basic Shares Outstanding
489.00M 490.00M 491.40M 493.00M
EPS (Diluted)
-1.0859 0.7621 0.6776 1.9617
EPS (Diluted) Growth
+19.19% +170.18% -11.09% +189.51%
Diluted Shares Outstanding
489.00M 493.40M 494.40M 496.50M
EBITDA
1.61B 2.13B 2.10B 2.40B
EBITDA Growth
+6.77% +32.26% -1.17% +14.22%
EBITDA Margin
+23.55% +25.67% +24.13% +25.40%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 101.263
Number of Ratings 30 Current Quarters Estimate 0.72
FY Report Date 12 / 2024 Current Year's Estimate 3.031
Last Quarter’s Earnings 0.81 Median PE on CY Estimate N/A
Year Ago Earnings 2.74 Next Fiscal Year Estimate 3.381
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 20 9 28 28
Mean Estimate 0.72 0.84 3.03 3.38
High Estimates 0.80 0.90 3.10 3.61
Low Estimate 0.69 0.79 2.92 3.15
Coefficient of Variance 4.27 3.66 0.94 3.02

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 21 21 18
OVERWEIGHT 3 3 3
HOLD 5 5 5
UNDERWEIGHT 1 1 1
SELL 0 0 1
MEAN Overweight Overweight Overweight

Alcon Ag in the News